Present address: Department of PNS Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
Inhibition of the transient receptor potential cation channel TRPM2 by 2-aminoethoxydiphenyl borate (2-APB)
Article first published online: 29 JAN 2009
2008 British Pharmacological Society
British Journal of Pharmacology
Volume 153, Issue 6, pages 1324–1330, March 2008
How to Cite
Togashi, K., Inada, H. and Tominaga, M. (2008), Inhibition of the transient receptor potential cation channel TRPM2 by 2-aminoethoxydiphenyl borate (2-APB). British Journal of Pharmacology, 153: 1324–1330. doi: 10.1038/sj.bjp.0707675
- Issue published online: 29 JAN 2009
- Article first published online: 29 JAN 2009
- (Received August 17, 2007, Revised November 8, 2007, Accepted December 11, 2007)
Background and purpose:
Transient receptor potential melastatin 2 (TRPM2) is a non-selective Ca2+-permeable cation channel and is known to be activated by adenosine 5′-diphosphoribose (ADP-ribose) and hydrogen peroxide. TRPM2 current responses are reported to be drastically potentiated by the combination of each of these ligands with heat. Furthermore, the combination of cyclic ADP-ribose with heat also activates TRPM2. Although flufenamic acid, antifungal agents (miconazole and clotrimazole), and a phospholipase A2 inhibitor (N-(p-amylcinnamoyl)anthranilic acid) inhibit TRPM2, their inhibition was either gradual or irreversible.
To facilitate future research on TRPM2, we screened several compounds to investigate their potential to activate or inhibit the TRPM2 channels using the patch-clamp technique in HEK293 cells, transfected with human TRPM2.
2-aminoethoxydiphenyl borate (2-APB) exhibited a rapid and reversible inhibition of TRPM2 channels that had been activated by its ADP-ribose or cADP-ribose and heat in a dose-dependent manner (IC50 about 1 μM). 2-APB also inhibited heat-evoked insulin release from pancreatic islets, isolated from rats.
Conclusions and implications:
2-APB proved to be a powerful and effective tool for studying the function of TRPM2.
British Journal of Pharmacology (2008) 153, 1324–1330; doi:10.1038/sj.bjp.0707675; published online 21 January 2008